Indo Amines Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
INDOAMIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 2.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Amines Limited reported strong FY 2025-26 results with standalone revenue growing 5.8% to Rs 1,11,797 lakh from Rs 1,05,658 lakh. Profit after tax jumped 29.9% to Rs 7,977 lakh versus Rs 6,140 lakh in the prior year. Operating margin expanded from 11.2% to 13.3%, indicating improved operational efficiency. The board recommended a final dividend of Rs 0.50 per share (10% on Rs 5 face value). The company also granted 5.6 lakh stock options under ESOP 2025 to eligible employees. Auditors issued an unmodified (clean) opinion on both standalone and consolidated results.
The 30% PAT growth and margin expansion are positive signals for shareholders. The stock could see support from strong earnings momentum, though the modest revenue growth of under 6% may limit upside. Dividend and ESOP grants demonstrate management confidence.